{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:22:16Z","timestamp":1793499736696,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Treatments that improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF) have shown no benefits for those with heart failure with preserved ejection fraction (HFpEF). Our study aimed to investigate the effect of inhaled iloprost on myocardial performance during exercise in HFpEF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study participants were enrolled from the ILO-HOPE trial (NCT03620526), a prospective randomized, double-blind, placebo-controlled study that was designed to investigate the effects of iloprost on cardiovascular hemodynamics during exercise in patients with HFpEF. Subjects were randomized 1:1 to inhalation of iloprost or placebo for 5 min. Two-dimensional transthoracic echocardiography with high temporal resolution was implemented to measure left ventricular (LV) longitudinal strain, LV diastolic function, and RV function both at rest and during supine exercise at 20-W workload.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      LV global longitudinal strain (GLS) in response to exercise increased more in the iloprost group (LV GLS, \u221224.96 \u00b1 1.20 vs \u221220.75 \u00b1 3.00,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Iloprost also resulted in greater increment of LV GLS during exercise (\u0394LV GLS, +6.02 \u00b1 1.39 vs +3.44 \u00b1 0.80,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Moreover, iloprost use was associated with enhancement of LV diastolic function, RV systolic function, and relief of pulmonary hypertension during exercise.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with HFpEF, inhaled iloprost favorably improved myocardial performance during exercise by increasing LV GLS reserve, decreasing LV diastolic filling load, and reducing stress-induced pulmonary hypertension and thereby improving RV systolic function. Larger studies are needed to validate the result and long-term benefits of iloprost in patients with HFpEF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1249\/mss.0000000000002145","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:57:59Z","timestamp":1567385879000},"page":"269-277","source":"Crossref","is-referenced-by-count":10,"title":["Inhaled Prostacyclin on Exercise Echocardiographic Cardiac Function in Preserved Ejection Fraction Heart Failure"],"prefix":"10.1249","volume":"52","author":[{"given":"CHEN-YU","family":"HUANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JEN-KUANG","family":"LEE","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, TAIWAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHENG-WEI","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JEN-FANG","family":"CHENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SSU-YUAN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIAN-YU","family":"LIN","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, TAIWAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHO-KAI","family":"WU","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, TAIWAN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"issue":"1","key":"bib1-20230822","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","year":"2012","journal-title":"Circulation"},{"issue":"23","key":"bib2-20230822","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jacc.2010.04.069","article-title":"Cystatin C and long-term 391 mortality among subjects with normal creatinine-based estimated glomerular filtration 392 rates: NHANES III (Third National Health and Nutrition Examination Survey)","volume":"56","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"bib3-20230822","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jacc.2017.09.006","article-title":"Biological phenotypes of heart failure with preserved ejection fraction","volume":"70","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"bib4-20230822","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/CCM.0b013e31820a91b9","article-title":"Plasma levels of tumor necrosis factor-alpha and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase","volume":"39","year":"2011","journal-title":"Crit Care Med"},{"issue":"3","key":"bib5-20230822","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/HJH.0b013e32831fda3a","article-title":"Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure","volume":"27","year":"2009","journal-title":"J Hypertens"},{"issue":"5","key":"bib6-20230822","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCULATIONAHA.115.015884","article-title":"Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone","volume":"132","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"bib7-20230822","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacc.2013.09.052","article-title":"Impaired systolic function by strain imaging in heart failure with preserved ejection fraction","volume":"63","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"138","key":"bib8-20230822","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1183\/16000617.0067-2015","article-title":"Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension","volume":"24","year":"2015","journal-title":"Eur Respir Rev"},{"issue":"1","key":"bib9-20230822","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/679725","article-title":"Pulmonary hypertension associated with heart failure with preserved ejection fraction: acute hemodynamic effects of inhaled iloprost","volume":"5","year":"2015","journal-title":"Pulm Circ"},{"issue":"10","key":"bib10-20230822","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrcardio.2016.134","article-title":"2016 ESC and ACC\/AHA\/HFSA heart failure guideline update\u2014what is new and why is it important?","volume":"13","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"bib11-20230822","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jacl.2017.08.018","article-title":"Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients","volume":"11","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"15","key":"bib12-20230822","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jacc.2015.07.067","article-title":"Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fraction","volume":"66","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"bib13-20230822","first-page":"17007","article-title":"Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices","volume":"19","year":"2015","journal-title":"Sci Rep"},{"issue":"11","key":"bib14-20230822","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/CIRCULATIONAHA.106.662882","article-title":"Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures","volume":"115","year":"2007","journal-title":"Circulation"},{"issue":"12","key":"bib15-20230822","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"bib16-20230822","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","year":"2011","journal-title":"Circulation"},{"issue":"38","key":"bib17-20230822","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/eurheartj\/ehv336","article-title":"Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial","volume":"36","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"bib18-20230822","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"bib19-20230822","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.14-0106","article-title":"Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study","volume":"146","year":"2014","journal-title":"Chest"},{"issue":"2","key":"bib20-20230822","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchf.2013.12.002","article-title":"Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction","volume":"2","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"5","key":"bib21-20230822","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hlc.2016.09.004","article-title":"Pilot study of Endothelin Receptor Blockade in Heart Failure with Diastolic Dysfunction and Pulmonary Hypertension (BADDHY-Trial)","volume":"26","year":"2017","journal-title":"Heart Lung Circ"},{"issue":"5","key":"bib22-20230822","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"issue":"11","key":"bib23-20230822","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"bib24-20230822","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/BF03017906","article-title":"Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension","volume":"49","year":"2002","journal-title":"Can J Anaesth"},{"issue":"5","key":"bib25-20230822","first-page":"319","article-title":"A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery","volume":"12","year":"2006","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"2","key":"bib26-20230822","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jclinane.2005.08.018","article-title":"Inhaled aerosolized iloprost in the evaluation of heart transplant candidates\u2014experiences with 45 cases","volume":"18","year":"2006","journal-title":"J Clin Anesth"},{"issue":"3","key":"bib27-20230822","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejphar.2005.05.017","article-title":"Effect of prostaglandin I2 analogues on left ventricular diastolic function in vivo","volume":"517","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"bib28-20230822","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2009.07.015","article-title":"A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension","volume":"104","year":"2010","journal-title":"Respir Med"},{"issue":"6","key":"bib29-20230822","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"bib30-20230822","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5603\/KP.a2016.0131","article-title":"Exercise-induced changes in left ventricular global longitudinal strain in asymptomatic severe aortic stenosis","volume":"75","year":"2017","journal-title":"Kardiol Pol"},{"issue":"3","key":"bib31-20230822","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/CRD.0000000000000172","article-title":"The prognostic implications of two-dimensional speckle tracking echocardiography in hypertrophic cardiomyopathy: current and future perspectives","volume":"26","year":"2018","journal-title":"Cardiol Rev"},{"issue":"1","key":"bib32-20230822","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"bib33-20230822","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.echo.2014.12.009","article-title":"Improvement in strain concordance between two major vendors after the strain standardization initiative","volume":"28","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"bib34-20230822","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0002-9149(78)90131-5","article-title":"Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects","volume":"41","year":"1978","journal-title":"Am J Cardiol"},{"issue":"6","key":"bib35-20230822","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/0735-1097(90)90378-3","article-title":"Comparison of hemodynamic responses during dynamic exercise in the upright and supine postures after orthotopic cardiac transplantation","volume":"16","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"bib36-20230822","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jchf.2018.03.003","article-title":"Hemodynamic correlates and diagnostic role of cardiopulmonary exercise testing in heart failure with preserved ejection fraction","volume":"6","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"5","key":"bib37-20230822","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","year":"2010","journal-title":"Circ Heart Fail"}],"container-title":["Medicine &amp; Science in Sports &amp; Exercise"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1249\/MSS.0000000000002145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:54:47Z","timestamp":1787324087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1249\/MSS.0000000000002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1249\/mss.0000000000002145","relation":{},"ISSN":["1530-0315","0195-9131"],"issn-type":[{"value":"1530-0315","type":"electronic"},{"value":"0195-9131","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,10]]}}}